Acute respiratory distress syndrome

Area of Science:

• Critical Care Medicine
• Pulmonology
• Pathophysiology

Background:

• Acute respiratory distress syndrome (ARDS) is a life-threatening lung condition common in intensive care units.
• It stems from an inciting event like pneumonia or sepsis, leading to a severe inflammatory response.
• ARDS can cause pulmonary edema, impaired gas exchange, and potentially lung fibrosis.

Purpose of the Study:

• To highlight the critical need for healthcare providers to identify and manage ARDS.
• To emphasize evidence-based management strategies in light of increased focus during the COVID-19 pandemic.

Main Methods:

• Review of existing literature on ARDS pathophysiology and clinical presentation.
• Analysis of inflammatory response mechanisms in ARDS.
• Synthesis of evidence-based guidelines for ARDS management.

Main Results:

• ARDS involves a dysregulated inflammatory cascade impacting lung function.
• Pulmonary edema and impaired gas exchange are key features.
• Fibrosis represents a potential long-term complication.

Conclusions:

• Effective identification and management of ARDS are vital for patient survival.
• Evidence-based practices are essential for healthcare providers, particularly in the context of emerging infectious diseases like COVID-19.
• Further research into ARDS pathophysiology may improve treatment outcomes.